Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Shares Outstanding (Weighted Average): 2015-2024

Historic Shares Outstanding (Weighted Average) for Kura Oncology (KURA) over the last 10 years, with Dec 2024 value amounting to $77.8 million.

  • Kura Oncology's Shares Outstanding (Weighted Average) rose 13.26% to $86.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.8 million, marking a year-over-year increase of 13.26%. This contributed to the annual value of $77.8 million for FY2024, which is 4.70% up from last year.
  • Per Kura Oncology's latest filing, its Shares Outstanding (Weighted Average) stood at $77.8 million for FY2024, which was up 4.70% from $74.3 million recorded in FY2023.
  • Over the past 5 years, Kura Oncology's Shares Outstanding (Weighted Average) peaked at $77.8 million during FY2024, and registered a low of $56.7 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $73.0 million, with a median of $74.3 million in 2023.
  • Data for Kura Oncology's Shares Outstanding (Weighted Average) shows a peak YoY climbed of 25.14% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Kura Oncology's Shares Outstanding (Weighted Average) stood at $56.7 million in 2020, then rose by 17.37% to $66.6 million in 2021, then increased by 0.51% to $66.9 million in 2022, then climbed by 11.02% to $74.3 million in 2023, then rose by 4.70% to $77.8 million in 2024.